We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma

    Background

    We aimed to characterize the clinical and multiphase computed tomography (CT) features, which can distinguish renal urothelial carcinoma...

    **n Chen, **ao Feng, ... Liling Long in BMC Urology
    Article Open access 03 January 2024
  2. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score

    Purpose

    Clear cell likelihood score (ccLS) may be a reliable diagnostic method for distinguishing renal epithelioid angiomyolipoma (EAML) and clear...

    Yu-Wei Hao, Yun Zhang, ... Hai-Yi Wang in Abdominal Radiology
    Article 25 September 2023
  3. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors

    Objectives

    Renal cell carcinoma (RCC) is infrequent among young adults. Few studies reported the outcome of RCC in young adults by pathological...

    Zixuan Xue, Shiying Tang, ... Shudong Zhang in World Journal of Urology
    Article 31 May 2024
  4. Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma

    The distinct pathological and molecular features of kidney cancer in adaptation to oxygen homeostasis render this malignancy an attractive model for...

    Chengheng Liao, Lianxin Hu, Qing Zhang in Nature Reviews Urology
    Article 02 May 2024
  5. Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (≤ 4 cm) solid renal masses

    Objective

    To evaluate a recently proposed CT-based algorithm for diagnosis of clear-cell renal cell carcinoma (ccRCC) among small (≤ 4 cm) solid renal...

    Fatma Eldihimi, Cynthia Walsh, ... Nicola Schieda in European Radiology
    Article 16 November 2023
  6. SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway

    SLFN11 is abnormally expressed and associated with survival outcomes in various human cancers. However, the role of SLFN11 in clear cell renal cell...

    He-** Wang, Zhi-Peng Zhao, ... Lei Yang in Medical Oncology
    Article 11 January 2024
  7. Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) presents a unique profile characterized by high levels of angiogenesis and robust vascularization....

    **peng Wang, Enyang Zhao, ... Xuedong Li in Oncogene
    Article Open access 11 March 2024
  8. Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound

    Background

    Non-clear cell renal cell carcinoma (nccRCC) represents a rare form of renal cell carcinoma (RCC) in the clinic. It is now understood that...

    Wei** Zhang, **gLing Wang, ... Jiayu Shi in BMC Urology
    Article Open access 17 June 2024
  9. Update on systemic therapy for clear cell renal cell carcinoma

    The treatment landscape of advanced and metastatic renal cell carcinoma (RCC) has changed fundamentally over the last two decades with the...

    Article 24 January 2023
  10. Exploring oncogenes for renal clear cell carcinoma based on G protein-coupled receptor-associated genes

    G protein-coupled receptors (GPCRs) are a class of receptors on cell membranes that regulate various biological processes in cells, such as cell...

    Chengcun Zhu, Zhou Sun, ... Baoluo Ma in Discover Oncology
    Article Open access 10 October 2023
  11. Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma

    Background

    Renal cell carcinoma (RCC) is a common primary tumor of the kidney and is divided into three major subtypes, of which clear cell renal cell...

    Article Open access 20 January 2024
  12. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma

    Background

    Clear cell renal cell carcinoma (ccRCC) is a prevalent cancer in adult urology, often leading to metastasis and poor prognosis. Recently,...

    Ke-Hao Pan, Liqing Yao, ... Zhixin Ling in European Journal of Medical Research
    Article Open access 19 September 2023
  13. TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma

    Background

    The tumor immune microenvironment plays a crucial role in the efficacy of various therapeutics. However, their correlation is not yet...

    Yaling Pu, Danyang Cai, ... Gang Wu in World Journal of Surgical Oncology
    Article Open access 23 May 2023
  14. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma

    Loss of function of the von Hippel-Lindau (VHL) tumor suppressor gene is a hallmark of clear cell renal cell carcinoma (ccRCC). The importance of...

    Junhui Hu, ** Tan, ... Lily Wu in Signal Transduction and Targeted Therapy
    Article Open access 17 April 2023
  15. Regional differences in clear cell metastatic renal cell carcinoma patients across the USA

    Purpose

    To test for regional differences in clear cell metastatic renal cell carcinoma (ccmRCC) patients across the USA.

    Methods

    The Surveillance,...

    Lukas Scheipner, Stefano Tappero, ... Pierre I. Karakiewicz in World Journal of Urology
    Article Open access 27 September 2023
  16. Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma

    Objective

    To compare the diagnostic efficiency of contrast-enhanced ultrasound (CEUS) with that of dynamic contrast-enhanced magnetic resonance...

    ** Zhao, Jianing Zhu, ... Qiuyang Li in European Radiology
    Article 01 February 2023
  17. ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway

    Clear cell renal cell carcinoma (ccRCC), with high mortality and poor prognosis, is the most common type of renal malignancy. It is necessary to...

    Yuming Liu, Dehua Zeng, Yunzhen Gao in Discover Oncology
    Article Open access 12 May 2024
  18. Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2

    Aldolase B (ALDOB), a glycolytic enzyme, is uniformly depleted in clear cell renal cell carcinoma (ccRCC) tissues. We previously showed that ALDOB...

    Mingyue Tan, Qi Pan, ... Jun Wang in Frontiers of Medicine
    Article 15 February 2023
  19. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy

    Background

    Long non-coding RNAs (lncRNAs) have been extensively investigated in the field of cancer, among which, lncRNA ladybird homeobox 2-antisense...

    Bao Wang, Yuang Wei, ... Pengfei Shao in European Journal of Medical Research
    Article Open access 07 February 2024
  20. Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression

    The secretagogin (SCGN) was originally identified as a secreted calcium-binding protein present in the cytoplasm. Recent studies have found that SCGN...

    Tuanjie Guo, Xuan Wang, ... **ang Wang in Discover Oncology
    Article Open access 03 June 2024
Did you find what you were looking for? Share feedback.